India’s Biopharma Shakti under Budget 2026 invests Rs 10,000 crore to expand NIPERs, establish 1,000 clinical trial sites, boost biosimilars, and train 1.5 lakh caregivers, aiming to transform India into a global pharmaceutical innovation hub. India is making its most ambitious bet yet on becoming a global biopharma powerhouse. Finance Minister Nirmala Sitharaman, presenting the …